Luke the Evangelist

DaVita Announces Dennis Pullin to its Board of Directors

Retrieved on: 
Wednesday, April 10, 2024
IA Financial Group, MedStar Health, MedStar Washington Hospital Center, DaVita Inc., Health equity, St Luke's, AUC, Virtua, Hospital, MedStar Harbor Hospital, Luke the Evangelist, Growth, Virtua Health, Health, Management

DENVER, April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024.

Key Points: 
  • DENVER, April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024.
  • "We're pleased to welcome Dennis to DaVita's board," said Pamela Arway, independent chair of the DaVita Inc. Board of Directors.
  • With the addition of Mr. Pullin, the DaVita Board is comprised of 11 highly qualified directors,  and our total board diversity has increased to over 50 percent.
  • To learn more about DaVita and its Board of Directors, visit DaVita.com/About .

Spirair Receives FDA Clearance for SeptAlign, the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation

Retrieved on: 
Monday, April 8, 2024
General Health, FDA, Surgery, Medical Devices, Health, NSD, Patient, NSR, St Luke's, NAO, ASC, Cartilage, Nose, FACS, Septum, University Health Network, Otorhinolaryngology, Physician, Luke the Evangelist, Food, IRB

This comes on the heels of FDA clearance of the SeptAlign bioabsorbable Implant in August 2023 and represents the final step in completing the FDA clearance process for the SeptAlign System.

Key Points: 
  • This comes on the heels of FDA clearance of the SeptAlign bioabsorbable Implant in August 2023 and represents the final step in completing the FDA clearance process for the SeptAlign System.
  • "Septal deviation is one of the primary contributors to nasal airway obstruction.
  • Physicians can't move septal cartilage with medicines so mechanical correction through surgery has been the best choice for many patients.
  • Following the clearance of the SeptAlign system, Spirair plans to begin a Series B fundraising round and start commercialization.

Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Retrieved on: 
Wednesday, February 21, 2024
Incidence, CHRS, Febrile neutropenia, Luke the Evangelist, Infection, Empowerment, Risk, Needlestick injury, Patient, OBI, NDC, Cancer

REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company's on-body injector (OBI) presentation of UDENYCA® (pegfilgrastim-cbqv), is successfully underway, with a broad distribution of accounts nationwide ordering this innovative device, and patients now accessing its benefits. UDENYCA is a pegfilgrastim biosimilar administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.

Key Points: 
  • UDENYCA is a pegfilgrastim biosimilar administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.
  • “The ONBODY device is the third presentation in the UDENYCA franchise, which also includes a prefilled syringe and autoinjector.
  • Where a cancer diagnosis takes empowerment away from patients, UDENYCA gives it back.”
    UDENYCA ONBODY is available through existing full-line and specialty distributors.
  • More details regarding UDENYCA ONBODY, including video instructions for ONBODY preparation and application, can be found at https://udenyca.com/hcp/onbody/ .

The American Diabetes Association Welcomes 2024 Principal Officers and Members to the National Board of Directors

Retrieved on: 
Wednesday, January 3, 2024
UCLA, Medicine, University, Pennsylvania State University, Bajaj, Public, Harvard University, Medicaid, Informatics, Johns Hopkins, Metabolism, Economics, Treatment, Medical Center, Luke the Evangelist, Conditional sentence, MBA, Harvard Business School, Urbański, Oregon State University, Doctor of Pharmacy, Anderson School of Management, Moda, Black, Medication, Baylor University, Bachelor of Science, Integrated delivery system, Division, Oklahoma State University–Stillwater, Kalyani, Education, Lee Ritenour, Medicare, Washington State University, Pharmacist, Committee on Finance, Cherokee Nation, Bon Secours Health System, Joslin Diabetes Center, Adventure, Management

ARLINGTON, Va., Jan. 3, 2024 /PRNewswire/ -- The American Diabetes Association® (ADA) welcomes the 2024 principal officers and board of directors.

Key Points: 
  • ARLINGTON, Va., Jan. 3, 2024 /PRNewswire/ -- The American Diabetes Association® (ADA) welcomes the 2024 principal officers and board of directors.
  • "We are so excited to announce our 2024 board of directors," said Charles "Chuck" Henderson, the ADA's chief executive officer.
  • We also want to thank our outgoing board members, Otis W. Kirksey, PharmD, RPh, CDCES, BC-ADM and Marshall Case.
  • We are very appreciative of their hard work, dedication, and commitment to fighting for all people affected by diabetes."

The Inner Circle Acknowledges, Dr. Cynthia Lubinsky as a Pinnacle Life Member

Retrieved on: 
Thursday, December 21, 2023
AOBFP, Bachelor of Science, Inner circle, Hospital, American Osteopathic Association, Multimedia, Infertility, Family medicine, Luke the Evangelist, Physician, Pennsylvania State University, St. Luke's Hospital, Certification, Knowledge, American College, Patient, Diagnosis, Nursing

POTTSVILLE, Pa., Dec. 21, 2023 /PRNewswire/ -- Dr. Cynthia Lubinsky's exceptional contributions to the field of Family Medicine have earned her recognition as a Pinnacle Life Member, as prominently featured in The Inner Circle.

Key Points: 
  • POTTSVILLE, Pa., Dec. 21, 2023 /PRNewswire/ -- Dr. Cynthia Lubinsky's exceptional contributions to the field of Family Medicine have earned her recognition as a Pinnacle Life Member, as prominently featured in The Inner Circle.
  • Her journey to excellence and dedication to comprehensive healthcare make her a standout figure in the medical community.
  • She embarked on her educational journey at Pennsylvania State University, where she earned her Bachelor of Science in Pre-Medical Studies.
  • As a board-certified family physician and osteopathic manipulative medicine specialist, Dr. Lubinsky is the first point of contact for many seeking healthcare services.

Santa Clara Family Health Plan announces Ria Paul, MD, as new Chief Medical Officer

Retrieved on: 
Thursday, December 14, 2023
Luke the Evangelist, Health equity, Temple University, SAN, Population health, Medical director, Clinical Associate (Psychology), St. Luke's Hospital, Stanford School, Federally Qualified Health Center, Internal medicine, Medicine, Health, Stanford University, Geriatrics, CMO, Growth, Stanford University Medical Center, University of Calcutta, Hospital, Nursing, Medical device, MD

SAN JOSE, Calif., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Santa Clara Family Health Plan (SCFHP) today announced the appointment of Ria Paul, MD, as its new Chief Medical Officer (CMO), effective December 18, 2023.

Key Points: 
  • Santa Clara Family Health Plan (SCFHP) announces Ria Paul, MD, as its new Chief Medical Officer (CMO).
  • SAN JOSE, Calif., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Santa Clara Family Health Plan (SCFHP) today announced the appointment of Ria Paul, MD, as its new Chief Medical Officer (CMO), effective December 18, 2023.
  • "I am honored to join Santa Clara Family Health Plan, an organization that has strived to provide equitable and accessible health care for Santa Clara County.
  • "I am honored to join Santa Clara Family Health Plan, an organization that has strived to provide equitable and accessible health care for Santa Clara County residents for more than 25 years," Dr. Paul said.

PathKeeper Surgical Celebrates the First Spine Surgery Performed with the PathKeeper 3D Optical Navigation System in Massachusetts

Retrieved on: 
Thursday, November 16, 2023
Luke the Evangelist, Radiation, Anatomy, St. Luke's Hospital, Hospital, Patient, FDA, Health, KFAR, MD, Southcoast Health System, Instrument, 3D, Operating, Dentistry, Nursing

KFAR SABA, Israel, Nov. 16, 2023 /PRNewswire/ -- PathKeeper Surgical, a privately-held, Israel-based, medical technology company, dedicated to improving the health of individuals around the world suffering from all spinal issues requiring surgery. While celebrating the first use of the PathKeeper 3D optical navigation system during a spinal fusion surgery at Southcoast Health's St. Luke's Hospital in New Bedford, Massachusetts, PathKeeper Surgical strives to make navigation-guided surgery available to any patient in all operating rooms.

Key Points: 
  • While celebrating the first use of the PathKeeper 3D optical navigation system during a spinal fusion surgery at Southcoast Health's St. Luke's Hospital in New Bedford, Massachusetts, PathKeeper Surgical strives to make navigation-guided surgery available to any patient in all operating rooms.
  • "We are thrilled at the adoption of the PathKeeper system at Southcoast Health, which continues our expansion of the PathKeeper system to hospitals and surgery centers across the United States," said Ryan LeBlanc, Chief Commercial Officer, PathKeeper Surgical.
  • PathKeeper Surgical received its FDA 510k clearance earlier this year for the PathKeeper system.
  • The name PathKeeper effectively describes the essence of the system – a 3D optical navigation system that 'keeps' the surgical 'path' on course throughout the surgery.

Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

Retrieved on: 
Thursday, November 9, 2023
Canadian Lung Association, American Cancer Society, Temple University School of Medicine, Incidence, American Lung Association, Lung cancer, Physician, University College, Oxford, United, Critical care, Death, Scan, Disease, Risk, Luke the Evangelist, CT, Woman, Olympus, Cancer, Patient, OCA, Medical imaging, St Luke's

CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.

Key Points: 
  • CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.
  • The event, "Breathing Life into Lung Cancer Awareness," will look at the current state of lung cancer in the U.S. and highlight the importance of early detection.
  • Olympus and the Lung Association want to help people understand who is at risk for lung cancer, for whom a screening is recommended based on the updated U.S Preventive Services Task Force guidelines and what a screening involves.
  • Dr. Stahlnecker, a paid consultant for Olympus, will also address the importance of lung cancer staging once cancer is diagnosed.

NEW REPORT SHOWS ST. LUKE'S UNIVERSITY HEALTH NETWORK SAVES $1 MILLION PER YEAR WITH ROUNDTRIP

Retrieved on: 
Wednesday, October 11, 2023
Workflow, University Health Network, Patient, Partnership, ETA, Luke the Evangelist, St Luke's, Transport, CIO, Patient satisfaction, Length of stay, Hospital, Nursing, Round trip

PHILADELPHIA, Oct. 11, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency. In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency. The study revealed $1 million savings annually through a 67% reduction in overnight stays due to transportation delays, along with averting the need to hire six additional communication center operators to manage the escalating volume of patient transportation requests.

Key Points: 
  • Roundtrip releases groundbreaking impact study revealing St. Luke's University Health Network achieves $1 million in cost savings per year by implementing its patient transportation software.
  • PHILADELPHIA, Oct. 11, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency.
  • In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency.
  • "Our collaboration with St. Luke's University Health Network is a testament to their dedication to embracing innovation," said Mark Switaj, CEO at Roundtrip.

NEW REPORT SHOWS ST. LUKE'S UNIVERSITY HEALTH NETWORK SAVES $1 MILLION PER YEAR WITH ROUNDTRIP

Retrieved on: 
Wednesday, October 11, 2023
Workflow, University Health Network, Patient, Partnership, ETA, Luke the Evangelist, St Luke's, Transport, CIO, Patient satisfaction, Length of stay, Hospital, Nursing, Round trip

PHILADELPHIA, Oct. 10, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency. In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency. The study revealed $1 million savings annually through a 67% reduction in overnight stays due to transportation delays, along with averting the need to hire six additional communication center operators to manage the escalating volume of patient transportation requests.

Key Points: 
  • Roundtrip releases groundbreaking impact study revealing St. Luke's University Health Network achieves $1 million in cost savings per year by implementing its patient transportation software.
  • PHILADELPHIA, Oct. 10, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency.
  • In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency.
  • "Our collaboration with St. Luke's University Health Network is a testament to their dedication to embracing innovation," said Mark Switaj, CEO at Roundtrip.